Keyphrases
Immune Response
100%
Hepatitis B Vaccine
100%
Immunization
100%
Hepatitis B Surface Antigen (HBsAg)
100%
PreS2
100%
S Vaccine
100%
Mammalian Cells
66%
Recombinant
66%
Yeast Product
66%
Pre-S
66%
HBV Vaccine
66%
Sci-B-Vac
66%
Travellers
33%
Cell-derived
33%
Dialysis
33%
Older Adults
33%
Clinical Trials
33%
Carrier Rate
33%
Renal Failure
33%
Hepatocellular Carcinoma
33%
Specific Risk
33%
Healthcare Workers
33%
People Health
33%
Epitope
33%
Hepatitis B
33%
Chronic Hepatitis B
33%
Immune Tolerance
33%
Non-responders
33%
HBV Replication
33%
Seroconversion
33%
Immunogenic
33%
Hepatitis
33%
Persistent HBV Infection
33%
Lamivudine
33%
Protocol Optimization
33%
Vietnam
33%
T Cell Exhaustion
33%
Recombinant Yeast
33%
Transplant Patients
33%
Enhanced Immunogenicity
33%
Seroprotection
33%
HBV Carrier
33%
Endemic Region
33%
Cost Profile
33%
Obese Men
33%
Immunology and Microbiology
Hepatitis B Vaccination
100%
Immune Response
100%
Hepatitis B Virus
100%
HBsAg
25%
Hepatitis B Surface Antibody
25%
Hepatitis B
25%
Hepatitis B Antigen
25%
Epitope
12%
Immune Tolerance
12%
Immunogenicity
12%
Hepatitis B Vaccine
12%
Human Immunodeficiency Virus
12%
Seroconversion
12%
High Risk Population
12%
T Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
100%
Hepatitis B
100%
Hepatitis B Antigen
25%
Hepatitis B Antibody
25%
Immunogenicity
12%
Recombinant
12%
HIV
12%
Clinical Trial
12%
Infection
12%
Liver Cell Carcinoma
12%
Kidney Failure
12%
Chronic Hepatitis B
12%
Lamivudine
12%
Hepatitis B Vaccine
12%
Epitope
12%